What's happening
This bill establishes a legal cause of action for individuals to seek medical monitoring damages after exposure to toxic substances, even without present injury.
Why it matters
Enables individuals exposed to toxic substances to seek court-ordered medical testing costs, even if they have no current symptoms. , which shifts legal focus from proving actual injury to demonstrating increased health risk and necessity of monitoring.
Defines broad eligibility for claims, including exposure to a wide range of chemicals, biological agents, and substances not yet officially classified as toxic. (as long as toxicity can be shown by evidence), potentially expanding the number and type of cases that can be brought.
Establishes clear criteria for bringing a suit—requiring proof of exposure, a probable link between the substance and a latent disease, increased risk, necessity of testing, and existence of diagnostic tests—aimed at balancing access to medical monitoring with safeguards against frivolous claims.
Affirms that this new legal path is in addition to existing remedies and explicitly allows class actions. , making it easier for groups affected by the same exposure incident to collectively seek medical monitoring, which could increase corporate and governmental accountability for environmental contamination.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Allow Medical Monitoring Lawsuits
Plain English, a few words. Used as the page title.
Sponsors
1 Co-sponsor
History
- Referred to environmental conservation
- Referred to environmental conservation
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Allow Medical Monitoring Lawsuits
In Assembly Committee · Codes · Sponsor Yuh-Line Niou
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
298
2021-2022 Regular Sessions
IN SENATE (Prefiled)
January 6, 2021
Introduced by Sen. THOMAS -- read twice and ordered printed, and when printed to be committed to the Committee on Environmental Conservation
AN ACT to amend the environmental conservation law and the civil practice law and rules, in relation to establishing a cause of action for medical monitoring
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The environmental conservation law is amended by adding a new section 37-0116 to read as follows: § 37-0116. Cause of action for medical monitoring.
1. For the purpose of this section, the following terms shall have the following meanings:
(a) "exposure" shall have the same meaning set forth in section two hundred fourteen-c of the civil practice law and rules.
(b) "toxic substance" shall mean:
(i) any chemical or biological substance that poses a risk to human health as defined by the commissioner pursuant to section 37-0103 of this title;
(ii) any substance categorized as toxic or hazardous by the United States environmental protection agency or the United States agency for toxic substance and disease registry shall be a hazardous or toxic substance; and
(iii) any substance not so characterized may be proven to be toxic by a preponderance of the evidence.
(c) "release" shall mean any intentional or unintentional, permitted or unpermitted, act or omission that allows a toxic substance to enter the air, land, surface water, groundwater, or any other place where the toxic substance may be located.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD03756-01-1
S. 298 2
(d) "medical monitoring" shall mean a program of medical surveillance, including medical tests or procedures for the purpose of early detection of signs or symptoms of latent disease resulting from exposure.
(e) "latent disease" shall mean any condition that negatively affects human health by causing death or permanent or protracted loss of mental or physical function which a person has a significantly increased risk of contracting.
(f) "reasonably necessary" shall mean the standard whereby a physician would prescribe testing for the purpose of detecting or monitoring the latent disease.
(g) "person" shall mean an individual, firm, corporation, association, partnership, consortium, joint venture, commercial entity, federal government, state, municipality, commission, political subdivision, or any interstate body.
2. A person with or without a present injury or disease shall have a cause of action for medical monitoring damages against a person who released a toxic substance if all of the following are demonstrated by a preponderance of the evidence:
(a) the person may have been exposed to the toxic substance as a result of the unauthorized release by the person who released the toxic substance;
(b) there is a probable link between exposure to the toxic substance and a latent disease;
(c) the person's exposure to the toxic substance increases the risk of developing the latent disease, provided that such person shall not be required to prove that the latent disease is certain or likely to develop as a result of the exposure;
(d) diagnostic testing is reasonably necessary; and
(e) medical tests or procedures exist to detect the latent disease.
3. Nothing in this section shall be construed to preclude the pursuit of any other civil or injunctive remedy available under statute or common law, including the right of any person to recover for damages related to the manifestation of a latent disease. The remedies in this section are in addition to those provided by existing statutory or common law.
4. This section does not preclude a court from certifying a class action for medical monitoring damages.
§ 2. The civil practice law and rules is amended by adding a new section 214-i to read as follows:
§ 214-i. Cause of action for medical monitoring. Notwithstanding any provision of law to the contrary, a cause of action for medical monitoring pursuant to section 37-0116 of the environmental conservation law, may be commenced by the plaintiff within the period allowed pursuant to section two hundred fourteen-c of this article or within one year of the effective date of this section.
§ 3. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the environmental conservation law and the civil prac- tice law and rules, in relation to establishing a cause of action for medical monitoring
Purpose or general idea of bill
To create an independent cause of action for medical monitoring.
Summary of provisions
Section one amends the environmental conservation law to create an inde- pendent cause of action for medical monitoring. The elements of a medical monitoring cause of action are:
1) the plaintiff's exposure to the toxic substance was due to unauthor- ized release of a toxic substance by the defendant;
2) there is a probable link between exposure to the toxic substance and the latent disease;
3) exposure to the toxic substance increased the plaintiff's risk of developing the latent disease;
4) diagnostic testing is reasonably necessary; and
5) medical tests or procedures exist to detect the latent disease.
Section two amends the civil practice law and rules to allow plaintiffs to bring a cause of action for medical monitoring within three years of discovery of the injury or within one year of the effective date of this article.
Section three is the effective date.
Justification
Across the country, courts have wrestled with awarding medical monitor- ing as a remedy in toxic tort claims brought by asymptomatic plaintiffs who might later develop injuries caused by exposure to toxic substances.
New York's Appellate court did not address the issue for a long time leaving lower courts to disagree on whether New York should recognize no-injury medical monitoring. This created three divergent lines of case law. Some courts recognized or upheld medical monitoring claims despite the fact that the plaintiff had not yet suffered a physical injury, and may never. Others required a "clinically-demonstrable presence of a toxin in the plaintiff's body, or some other indication of a toxin-in- duced disease" or rejected outright an independent claim for medical monitoring.
When the Appellate Court finally reviewed medical monitoring in Caronia v., Philip Morris USA, Inc. it ruled that New York does not recognize an independent medical monitoring cause of action. 2013. N.Y. LEXIS 3476, 2013 N.Y. Slip. Op. 8372. The Caronia majority decided that deien- dant resources were best committed to paying individuals with actual injuries instead of diverting costs to paying for monitoring. The dissenting minority responded: "Where, as here, it is within the Court's power to provide a vehicle for plaintiffs to seek equitable relief capa- ble of forestalling profound, suffering and death, judicial hesitance and legislative deference only serve to thwart the ends of justice."
This bill would allow individuals to seek the costs of periodic, future medical examinations intended to facilitate early diagnosis and treat- ment of latent injuries or diseases caused by exposure to toxic substances.
Prior legislative history
2020: S.8145 (Thomas) - Referred to Environmental Conservation Committee/A.10762 Rules (Niou) - Referred to Judiciary Committee.
Fiscal implications
None noted to the State.
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.